Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
Eli Lilly and Company
Spanish Lung Cancer Group
Astellas Pharma Inc
Kadmon Corporation, LLC
Genentech, Inc.
Hoffmann-La Roche
Novartis
Dartmouth-Hitchcock Medical Center
Hospices Civils de Lyon
The Netherlands Cancer Institute
Boehringer Ingelheim
National Cancer Institute (NCI)
Sanofi
Daiichi Sankyo
Astellas Pharma Inc
Pfizer
Hoffmann-La Roche
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
National Cancer Institute (NCI)
Astellas Pharma Inc
Hoffmann-La Roche
Hoffmann-La Roche
Hoffmann-La Roche
Hoffmann-La Roche
Hoffmann-La Roche
University College, London
Tongji University
Genentech, Inc.
Xinjiang Medical University
Pfizer
National Cancer Institute (NCI)
Pfizer
Genentech, Inc.
Fatebenefratelli and Ophthalmic Hospital
Hellenic Oncology Research Group
Zhejiang Cancer Hospital
Tel-Aviv Sourasky Medical Center